Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human primary basal cell (BC) or iPSC-derived basal cell (iBC) recipients (6 weeks post-transplantation)

ABSTRACT: The goal of this experiment is to study the transcriptome of

ORGANISM(S): Mus musculus

PROVIDER: GSE211997 | GEO | 2023/08/24

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Human primary basal cell (BC) or iPSC-derived basal cell (iBC) recipients (6 weeks post-transplantation)

Project description:Human primary basal cell (BC) or iPSC-derived basal cell (iBC) recipients (6 weeks post-transplantation)

| PRJNA873119 | ENA

murine primary basal cell (BC) recipient (69 days post-transplantation) and ESC-derived basal cell (iBC) recipient (192 days post-transplantation)

Project description:The goal of the experiment is to: 1) compare transcriptome of primary BC-derived lineages to endogenous tracheal epithelial cells after transplantation; 2) compare the transcriptome of iBC-derived lineages to their endogenous counterparts, and study them together with a previous dataset of iBC recipient 40&56 days post-transplantation to study any temporal changes

2023-08-24 | GSE211996 | GEO

murine ESC-derived basal cell (iBC) transplantation (40&56 days post-transplantation)

Project description:The goal of this experiment was to compare the transcriptome of iBC-derived lineages to endogenous tracheal epithelial cells after transplantation.

2023-08-24 | GSE211995 | GEO

murine primary basal cell (BC) recipient (69 days post-transplantation) and ESC-derived basal cell (iBC) recipient (192 days post-transplantation)

Project description:murine primary basal cell (BC) recipient (69 days post-transplantation) and ESC-derived basal cell (iBC) recipient (192 days post-transplantation)

| PRJNA873120 | ENA

murine ESC-derived basal cell (iBC) transplantation (40&56 days post-transplantation)

Project description:murine ESC-derived basal cell (iBC) transplantation (40&56 days post-transplantation)

| PRJNA873117 | ENA

BC and iBC

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-08-24 | GSE211998 | GEO

Murine ESC-derived basal cell (iBC) 5th generation secondary transplantation

Project description:The goal of this experiment was to compare the transcriptome of iBC-derived lineages to endogenous tracheal epithelial cells after transplantation after serial secodnary transplantation.

2023-08-24 | GSE232544 | GEO

BC and iBC

Project description:BC and iBC

| PRJNA873115 | ENA

Murine ESC-derived basal cell (iBC) 5th generation secondary transplantation

Project description:Murine ESC-derived basal cell (iBC) 5th generation secondary transplantation

| PRJNA972700 | ENA

Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.

Project description:This paper reports for the first time three cases of infection by HTLV-I via organ transplantation; all the organs coming from the same asymptomatic infected donor. The need is considered for the implementation of compulsory screenings for HTLV antibodies on organ donors and on blood banks.The determination of antibodies for HTLV-I/II on samples of serum and cerebral spinal fluid from the patients and the donor was performed by enzyme immunoassay and western blot. Analysis of proviral DNA was performed by polymerase chain reaction. To detect changes in the sequence of amino acids, the tax gene was sequentiated, amplified, and compared with ATK prototype stocks. Spinal cord magnetic resonance imaging, cerebral spinal fluid, and somatosensory evoked potential studies were carried out in all patients.All three transplanted patients developed a myelopathy within a very short period of time. In all three patients and donor the virus belonged to the Cosmopolitan A subtype. The homology of HTLV-I sequences recovered from the patients and donor was 100% in all four cases. Proviral load was high in all three patients. The factors that certainly contributed to the infection in the first place, and the development of the disease later, were on the one hand the high proviral load and their immunosuppressed condition, and on the other the virus genotype, which proved to be an aggressive variant. However, the analysis of the histocompatibility antigen showed that two of the patients carried an haplotype that has been associated with a lower risk of developing this disease.It is argued that, although in Spain and other European countries there is not compulsory screening for HTLV antibodies because of the studies that show a low seroprevalence, in view of the cases here reported, and to avoid the serious consequences that such infection has on transplanted patients, compulsory screenings, both on organ donors and on blood banks, should be implemented.

| S-EPMC1738581 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data